期刊文献+

EXPRESSION OF IMMUNE-RELATED MOLECULES IN GLIOBLASTOMA MULTIFORM CELLS

EXPRESSION OF IMMUNE-RELATED MOLECULES IN GLIOBLASTOMA MULTIFORM CELLS
下载PDF
导出
摘要 Objective: To investigate the expression of immune- related molecules in glioblastoma multiform(GBM) cells. Methods: The expression of major histocompatibility complex (MHC), b2-microglobulin, Fas, CD80 and CD86 molecules on the surface of GBM cells were evaluated by flow cytometry. The expression of TAP-1, TAP-2 and Tapasin in the GBM cells were evaluated by RT-PCR method. Results: MHC class I, b2 microglobulin, TAP-1, TAP-2 and tapasin were expressed in most GBM cell lines. Except U87, there was no MHC class II molecule expression on any of the other GBM cell lines. Fas was expressed on all the GBM cell lines examined. Conclusion: The mechanism by which GBM escapes immune surveillance may involve down regulation of expression of MHC class I molecules and MHC class II molecules. MHC class I positive GBM may be the suitable target of immunotherapy. Objective: To investigate the expression of immune- related molecules in glioblastoma multiform(GBM) cells. Methods: The expression of major histocompatibility complex (MHC), b2-microglobulin, Fas, CD80 and CD86 molecules on the surface of GBM cells were evaluated by flow cytometry. The expression of TAP-1, TAP-2 and Tapasin in the GBM cells were evaluated by RT-PCR method. Results: MHC class I, b2 microglobulin, TAP-1, TAP-2 and tapasin were expressed in most GBM cell lines. Except U87, there was no MHC class II molecule expression on any of the other GBM cell lines. Fas was expressed on all the GBM cell lines examined. Conclusion: The mechanism by which GBM escapes immune surveillance may involve down regulation of expression of MHC class I molecules and MHC class II molecules. MHC class I positive GBM may be the suitable target of immunotherapy.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2003年第2期112-115,共4页 中国癌症研究(英文版)
关键词 GBM (glioblastoma multiform) IMMUNE MHC (major histocompatibility complex) GBM (glioblastoma multiform), Immune, MHC (major histocompatibility complex)
  • 相关文献

参考文献15

  • 1Parney IF, Hao C, Petruk KC. Glioma immunology and immunotherapy[J]. Neurosurgery 2000; 46: 778--91.
  • 2Schnurr M, Galambos E Scholz C, et al. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccine[J]. Cancer Res 2001; 61: 6445--50.
  • 3Ni HT, Spellman SR, Jean WC, et al. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas[J]. J Neurooncol 2001; 51: 1 -- 9.
  • 4Yu JS, Wheeler CJ, Zeltzer PM, et al. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration[J]. Cancer Res 2001; 61: 842--7.
  • 5Morford LA, dix AR, Brooks WH, et al. Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors[J]. J Neurosurg 1999; 91:935--46.
  • 6Liau LM, Black KL, Prins RM, et al. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens[J]. J Neurosurg 1999; 90:1115--24.
  • 7Elliott LH, Brooks WH, Roszman TL. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors[J]. J Immunol 1984; 132:1208-- 15.
  • 8McVicar DW, Davis DE merchant RE. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect[J]. J Neurosurg 1992;76:251--60.
  • 9Dix AR, Brooks WH, Roszman TL, et al. Immune defects observed in patients with primary malignant brain tumors[J]. J Neuroimmunol 1999; 100: 216--32.
  • 10Morford LA, EUiott LH, Carlson SL, et al. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors[J]. J Immunol 1997; 159: 4415--25.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部